Pignot, Géraldine
Maillet, Denis
Gross, Emmanuel
Barthelemy, Philippe
Beauval, Jean-Baptiste
Constans-Schlurmann, Friederike
Loriot, Yohann
Ploussard, Guillaume
Sargos, Paul
Timsit, Marc-Olivier
Vincendeau, Sébastien
Pasticier, Gilles
Borchiellini, Delphine
Article History
First Online: 15 May 2018
Competing interests
: G. Pignot is a consultant for Sanofi and Janssen. D.M. is a consultant for Janssen. E.G. is a consultant for Janssen and Sanofi. J.-B.B. is a consultant for Astellas, Ferring, Ipsen, and Janssen. F.C.-S. is a consultant for Astellas, Janssen, and Sanofi. Y.L. is a consultant for Astellas, Janssen, Sanofi, MSD, Roche, and AstraZeneca and has received research funding from Sanofi. G. Ploussard is an advisory board member and a consultant for Astellas, Ferring, IPSEN, Janssen, and Pierre Fabre. P.S. is a consultant and expert for Astellas, AstraZeneca, Ferring, Ipsen, Janssen, Nanobiotix, Roche, Sanofi, and Takeda. M.-O.T. was an invited speaker in symposia organized by Janssen, Astellas, and Pfizer. S.V. is a consultant for Astellas, Janssen, and Sanofi. G. Pasticier is a consultant for Astellas, Janssen, and Sanofi. D.B. is a consultant and advisory board member for Janssen, Sanofi, and Ipsen.